Heart disease is a leading cause of morbidity and death. With Americans often suffering from a poor diet, leading to obesity and metabolic syndrome, the growing trend of heart disease continues in the U.S.A. Patients that have a history of heart failure, myocardial infarction, enlarged heart due to cardiomyopathy, previous history of bypass cardiac surgery, or stents and report of “low ejection fractions” should consider stem cell treatment.
We request lab reports of the patient’s cardiac enzymes, cholesterol, triglycerides, HDL, LDL, reports of the echocardiogram and stress echocardiogram, EKG and Holter monitor for evaluating cardiac rhythm.
Treatment by Stem Cell Genetic Med consists of the following:
- Stimulation of the patient’s own stem cell niches in the heart with oral and injectable agents.
- Autologous stem cells taken from patient’s bone marrow or peripheral blood.
- Cardiac stem cell precursors (cardiomyocytes) extracted from umbilical cord blood, precursor CD 34+ and CD 133+ cells mixed with stem cell factor, and at times mixed with a specific antibody that promotes the engraftment of the stem cells into heart muscle (myocardium).
- The stem cells can be administered intravenously which migrate only to the damaged heart muscle. The survival of these stem cells are assisted by the co-administration of stem cell factor and vascular endothelial growth factor. Initially, we recommend the above non-invasive approach. The patient is followed and tested regularly over the next six months.
- Only if there is insufficient cardiac improvement measured by ejection fraction, would the patient get a repeat treatment of the cardiac stem cells, but would be administered this time through cardiac catherization to the aortic arch.
- The patient will be on a cardiac rehabilitation program supervised by a cardiologist. In addition, continued stimulation of cardiac stem cell niches with oral and injectable agents as well as the transplanted cardiomyocytes will continue for the next six months or longer.
Post stem therapy program medications are then given to the patient to be taken for six months. Patients who travel a distance, whether by plane or automobile, to receive this treatment should have received a pneumovax and flu vaccine within the last three years. In severe cases of emphysema and COPD, the use of short term inhalers and prophylactic antibiotics may be advisable to prevent secondary infections because of fatigue of traveling, exposure to secondary infections, and decreased immune system. Eat lots of broccoli and apples that are rich in anti-oxidants. An intake of Retinoic acid of 100 mg and alpha-tocopherol 1200 mg per day are recommended.
Contact us today to book an appointment and discuss the best way to treat your condition or that of any member of your family – with stem cell treatment options. 561-557-3358